Physico-chemical and structural characterization of diacerhein

Journal of Pharmaceutical and Biomedical Analysis

Volumn 49, Issue 4, 2009, Pages 1065-1069

  Bambagiotti Alberti, Massimo ^a   Bartolucci, Gianluca ^a   Bruni, Bruno ^a   Coran, Silvia A ^a   Di Vaira, Massimo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Crystal structure; Diacerhein; Infrared spectroscopy; Thermal analysis; X ray powder diffraction

Indexed keywords

DIACETYLRHEIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG INFORMATION; DRUG STRUCTURE; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; X RAY CRYSTALLOGRAPHY; X RAY POWDER DIFFRACTION;

ANTHRAQUINONES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; DIFFERENTIAL THERMAL ANALYSIS; HYDROGEN BONDING; MOLECULAR CONFORMATION; REFERENCE STANDARDS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TABLETS;

EID: 62749154552     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.01.018     Document Type: Article

References (29)

1. Pomarelli P., Berti M., Gatti M.T., and Mosconi P. Farmaco 35 (1980) 836-842
2. Mian M., Benetti D., Rosini S., and Fantozzi R. Pharmacology 39 (1989) 362-366
3. Nguyen M., Dougados M., Berdah L., and Amor B. Arthritis Rheum. 37 (1994) 529-536
4. Pelletier J.-P., Yaron M., Haraoui B., Cohen P., Nahir M.A., Choquette D., Wigler I., Rosner I.A., and Beaulieu A.D. Arthritis Rheum. 43 (2000) 2339-2348
5. Debord P., Louchahi K., Tod M., Cournot A., Perret G., and Petitjean O. Eur. J. Drug Metab. Pharmacokinet. 19 (1994) 13-19
6. Mian M., Brunelleschi S., Tarli S., Rubino A., Benetti D., Fantozzi R., and Zilletti L. J. Pharm. Pharmacol. 39 (1987) 845-847
7. Spencer C.M., and Wilde M.I. Drugs 53 (1997) 98-106 (discussion 107-108)
8. Mian M., Trombi L., Rosini S., Benetti D., Caracciolo F., Carulli G., Azzara A., and Ambrogi F. Drugs Exp. Clin. Res. 13 (1987) 695-698
9. Moore A.R., Greenslade K.J., Alam C.A., and Willoughby D.A. Osteoarthritis Cartilage 6 (1998) 19-23
10. Tamura T., and Ohmori K. Eur. J. Pharmacol. 419 (2001) 269-274
11. Pelletier J.-P., Lajeunesse D., Reboul P., Mineau F., Fernandes J.C., Sabouret P., and Martel-Pelletier J. J. Rheumatol. 28 (2001) 814-824
12. Solignac M. Presse Med. 33 (2004) S10-12
13. T. Cruz, A. Pastrak, Use of rhein or diacerhein compounds for the treatment or prevention of vascular diseases, 2004.
14. M. Sinistri, R. Sinistri, Manufacture of pure 1,8-diacetoxy-3-carboxyanthraquinone (diacerein) from aloin, 98-EP3221 9856750, 19980529 (1998).
15. D. Maggi, Extraction process for purifying diacerein, 2003-EP13194 2004050601, 20031124 (2004).
16. Bernstein J. Polymorphism in Molecular Crystals (2002), Clarendon Press, Oxford
17. Hilfiker R. Polymorphism in the Pharmaceutical Industry (2006), Wiley VCH, Weinheim
18. Oxford Diffraction, CrysAlisPro CCD and CrysAlisPro RED, versions 1.171.29.2, and ABSPACK in CrysAlisPro RED, Oxford Diffraction Ltd., Abingdon, Oxfordshire, England, 2006.
19. Altomare A., Burla M.C., Camalli M., Cascarano G.L., Giacovazzo C., Guagliardi A., Moliterni A.G.G., Polidori G., and Spagna R. J. Appl. Cryst. 32 (1999) 115-119
20. Sheldrick G.M. Acta Cryst. A64 (2008) 112-122
21. Nardelli M. J. Appl. Cryst. 28 (1995) 659
22. Farrugia L.J. J. Appl. Cryst. 30 (1997) 565
23. Speck A.L. J. Appl. Cryst. 36 (2003) 7-13
24. Macrae C.F., Edgington P.R., McCabe P., Pidcock E., Shields G.P., Taylor R., Towler M., and van de Streek J. J. Appl. Cryst. 39 (2006) 453-457
25. Gu S.-J., Jing L.-H., Zang H.-X., and Qin D.-B. Acta Cryst. E63 (2007) o563-o564
26. Kampmann B., Lian Y., Klinkel K.L., Vecchi P.A., Quiring H.L., Soh C.C., and Sykes A.G. J. Org. Chem. 67 (2002) 3878-3883
27. Gill M., Morgan P.M., White J.M., and Yu J. Aus. J. Chem. 51 (1998) 213-218
28. Norvez S., Tournilhac F.-G., Bassoul P., and Herson P. Chem. Mater. 13 (2001) 2552-2561
29. Nakanishi W., Nakamoto T., Hayashi S., Sasamori T., and Tohitoh N. Chem. Eur. J. 13 (2007) 255-268